Inicio Zine News Trillium Therapeutics Appoints Jan Skvarka as President and Chief Executive Officer

Trillium Therapeutics Appoints Jan Skvarka as President and Chief Executive Officer

5
0
Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)